Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin H Adelman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Diabetes Science and Technology|March 24, 2010
Glucose supply and insulin demand dynamics of antidiabetic agentsScott V Monte, Jerome J Schentag, Martin H Adelman, et al.
Pharmacoeconomics|July 21, 2007
Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the USJoseph A Paladino, Martin H Adelman, Jerome J Schentag, et al.
Journal of the American Geriatrics Society|May 12, 2007
Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumoniaJoseph A Paladino, David A Eubanks, Martin H Adelman, et al.
Journal of Diabetes Science and Technology|March 24, 2010
Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand modelScott V Monte, Jerome J Schentag, Martin H Adelman, et al.
Surgical Infections|June 24, 2008
Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infectionsJoseph A Paladino, Kristin K Gilliland-Johnson, Martin H Adelman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 25, 2007
Observations on vancomycin use in U.S. hospitalsJoseph A Paladino, Jenna L Sunderlin, Martin H Adelman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 11, 2008
Influence of extended-spectrum beta-lactams on gram-negative bacterial resistanceJoseph A Paladino, Jenna L Sunderlin, Mendel E Singer, et al.
International Journal of Antimicrobial Agents|June 26, 2007
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled studyJerome J Schentag, Keith P Klugman, Victor L Yu, et al.
International Journal of Antimicrobial Agents|October 6, 2014
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrationsJoseph A Paladino, David M Jacobs, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|October 7, 2008
A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibioticThomas M File, Scott V Monte, Jerome J Schentag, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Diabetes Science and Technology|March 24, 2010
Glucose supply and insulin demand dynamics of antidiabetic agentsScott V Monte, Jerome J Schentag, Martin H Adelman, et al.
Pharmacoeconomics|July 21, 2007
Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the USJoseph A Paladino, Martin H Adelman, Jerome J Schentag, et al.
Journal of the American Geriatrics Society|May 12, 2007
Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumoniaJoseph A Paladino, David A Eubanks, Martin H Adelman, et al.
Journal of Diabetes Science and Technology|March 24, 2010
Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand modelScott V Monte, Jerome J Schentag, Martin H Adelman, et al.
Surgical Infections|June 24, 2008
Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infectionsJoseph A Paladino, Kristin K Gilliland-Johnson, Martin H Adelman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 25, 2007
Observations on vancomycin use in U.S. hospitalsJoseph A Paladino, Jenna L Sunderlin, Martin H Adelman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 11, 2008
Influence of extended-spectrum beta-lactams on gram-negative bacterial resistanceJoseph A Paladino, Jenna L Sunderlin, Mendel E Singer, et al.
International Journal of Antimicrobial Agents|June 26, 2007
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled studyJerome J Schentag, Keith P Klugman, Victor L Yu, et al.
International Journal of Antimicrobial Agents|October 6, 2014
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrationsJoseph A Paladino, David M Jacobs, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|October 7, 2008
A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibioticThomas M File, Scott V Monte, Jerome J Schentag, et al.
Pageof 1